Study to Evaluate the Efficacy, Tolerability and Safety of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases

Condition:   Primary Immune Deficiency Disorder Intervention:   Biological: Octanorm Sponsor:   Octapharma Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials